ASRS 2021: Over the Long Term, Visual Acuity With Anti-VEGF Therapy Worsens More Than Seen in RCTs
Real world experience was examined in a database review.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.